Explore All Access
Check if your research matches the topics covered in Neurotherapeutics?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Neurotherapeutics : Impact Factor & More
eISSN: 1878-7479pISSN: 1933-7213
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Neurotherapeutics Key Metrics
CiteScore 
10
Eigenfactor
0.005 - 0.01
Impact Factor
5 - 10
SJR
Q1Pharmacology
SNIP
1.75
Topics Covered on Neurotherapeutics
Disease
Multiple sclerosis
Spinal cord
Antigen
Ursodeoxycholic acid
Central nervous system
Fragile x
Parkinson's disease
Migraine
Functional recovery
Brain-derived neurotrophic factor
Tuberous sclerosis
Neuropathic pain
Sleep research
Cognitive impairment
Experimental autoimmune encephalomyelitis
Clinical trial
Neurology
Neurogenesis
Prostaglandin
Neurotherapeutics Journal Specifications
| Overview | |
| Publisher | SPRINGER |
| Language | English |
| Frequency | Quarterly |
| General Details | |
| Language | English |
| Frequency | Quarterly |
| Publication Start Year | 2004 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
One subscription packed with expert publication services and AI tools to get you published
Brought to you by 
Journal Selection Service
Benefit from our experts' recommendations of 3-5 best-suited journals, accompanied by a detailed Journal Selection report explaining the choices. Make informed decisions.
Journal Submission Service
Streamline your submission process with meticulous manuscript formatting to meet journal guidelines, crafting a tailored cover letter for the editor, and hassle-free account creation and submission
Bundle of AI tools for your research needs
Journal Finder, Paperpal, R Discovery, MindTheGraph and more
Planning to publish in Neurotherapeutics ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Neurotherapeutics
A Phase 1b, Open-Label Study to Evaluate the Safety and Tolerability of the Putative Remyelinating Agent, Liothyronine, in Individuals with MS
- 17 Jul 2023
- Neurotherapeutics
Long-Term Effect of Switching From an Anti-CGRP Receptor to an Anti-CGRP Ligand Antibody in Treatment-Refractory Chronic Migraine: A Prospective Real-World Analysis
- 10 Jul 2023
- Neurotherapeutics
A Real-Time Neurophysiologic Stress Test for the Aging Brain: Novel Perioperative and ICU Applications of EEG in Older Surgical Patients
- 1 Jul 2023
- Neurotherapeutics
Anti-Amyloid Immunotherapies for Alzheimer’s Disease: A 2023 Clinical Update
- 1 Jul 2023
- Neurotherapeutics
Axonal Transport Defect in Gigaxonin Deficiency Rescued by Tubastatin A
- 2 Jun 2023
- Neurotherapeutics
Machine Learning in Clinical Trials: A Primer with Applications to Neurology
- 30 May 2023
- Neurotherapeutics
A Phase 1b, Open-Label Study to Evaluate the Safety and Tolerability of the Putative Remyelinating Agent, Liothyronine, in Individuals with MS
- 17 Jul 2023
- Neurotherapeutics
Long-Term Effect of Switching From an Anti-CGRP Receptor to an Anti-CGRP Ligand Antibody in Treatment-Refractory Chronic Migraine: A Prospective Real-World Analysis
- 10 Jul 2023
- Neurotherapeutics
A Real-Time Neurophysiologic Stress Test for the Aging Brain: Novel Perioperative and ICU Applications of EEG in Older Surgical Patients
- 1 Jul 2023
- Neurotherapeutics
Anti-Amyloid Immunotherapies for Alzheimer’s Disease: A 2023 Clinical Update
- 1 Jul 2023
- Neurotherapeutics
Axonal Transport Defect in Gigaxonin Deficiency Rescued by Tubastatin A
- 2 Jun 2023
- Neurotherapeutics
Machine Learning in Clinical Trials: A Primer with Applications to Neurology
- 30 May 2023
- Neurotherapeutics
Compare Similar Journals with Neurotherapeutics
Select Journals to Compare with Neurotherapeutics
Total journals - 8
You can select up to 3 Journals at a time
International Journal of Molecular Sciences
Publisher: MDPI
Scientific Reports
Publisher: NATURE PORTFOLIO
Frontiers in Neurology
Publisher: FRONTIERS MEDIA SA
PLoS ONE
Publisher: PUBLIC LIBRARY SCIENCE
Frontiers in Neuroscience
Publisher: FRONTIERS MEDIA SA
Frontiers in Pharmacology
Publisher: FRONTIERS MEDIA SA
Neurology
Publisher: LIPPINCOTT WILLIAMS & WILKINS
Journal of the Neurological Sciences
Publisher: ELSEVIER
0 Journals Selected to compare with
Neurotherapeutics
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on Neurotherapeutics
How long has Neurotherapeutics been actively publishing? 
Neurotherapeutics has been in operation since 2004 till date.
What is the publishing frequency of Neurotherapeutics?
Neurotherapeutics published with a Quarterly frequency.
How many articles did Neurotherapeutics publish last year?
In 2023, Neurotherapeutics publsihed 20 articles.
What is the eISSN & pISSN for Neurotherapeutics?
For Neurotherapeutics, eISSN is 1878-7479 and pISSN is 1933-7213.
What is Citescore for Neurotherapeutics?
Citescore for Neurotherapeutics is 10.
What is SNIP score for Neurotherapeutics?
SNIP score for Neurotherapeutics is 1.75.
What is the SJR for Neurotherapeutics?
SJR for Neurotherapeutics is Q1.
Who is the publisher of Neurotherapeutics?
SPRINGER is the publisher of Neurotherapeutics.
